我们根据提供的电话会议记录来判断。管理层提到了多个具体事件:ProTmune临床试验方案修改并开始入组,FATE-NK100提交IND,ToleraCyte获得FDA积极反馈,与纪念斯隆凯特琳合作,以及多个监管指定(快速通道、孤儿药)。这些是具体事件。管理层也将其描述为进展,并说“substantial progress”和“intensified our clinical commitment”,但需要看是否明确将这些事件连接成一个更广泛的早期模式。管理层说“we have delivered substantial progress and intensified our clinical commitment to each of our programs”,并列举了这些事件。但模式是否“still early”?管理层提到“we have now initiated clinical translation of our first off-the-shelf product candidate”等,但整体上,这些事件是独立的进展,管理层没有明确说“这些是更大趋势的开始,更多即将到来”这样的表述。他们确实说“we believe we are well-positioned to rapidly deliver robust results”等,但更多是展望。另外,这些事件是近期发生的,但管理层是否将它们视为“leading edge of a broader improvement that is still early”?在ProTmune部分,他们提到“we believe that with the implementation of this protocol amendment we are well-positioned to rapidly deliver robust results that can enable confident decision-making and potentially support an accelerated registration strategy” — 这有点连接。但整体上,管理层没有明确说“这些是早期迹象,更多正在形成”。他们更多是报告进展。另外,注意问题要求“management explicitly treats these accumulating episodes as the LEADING EDGE of a broader improvement that is still early”。管理层在总结时说“Over the past several months we have delivered substantial progress and intensified our clinical commitment to each of our programs.” 然后列举了具体事件,但并没有明确说“这些是更广泛改进的前沿,且仍处于早期”。他们确实说“we have the opportunity to be the first group to ever advance an engineered iPSC-derived cancer immunotherapy into clinical development”等,但那是关于未来的。我认为管理层没有明确地将这些具体事件连接成一个“still early”的模式。他们只是报告了进展。另外,这些事件是否都是“ground-level wins”?是的,比如IND提交、临床试验方案修改、合作等。但问题要求“management explicitly connects the episodes into a building pattern that is still early”。管理层在最后说“we have made substantial progress and intensified our clinical commitment”但并没有说“这些是早期迹象,更多即将到来”。他们确实说“we look forward to discussing with the FDA our path to become the first group to advance an engineered induced pluripotent cell line derived cancer immunotherapy into clinical development” — 那是未来计划。所以我认为答案可能是NO,因为管理层没有明确地将这些事件连接成一个更广泛的早期模式。他们只是报告了各个进展。另外,注意问题要求“management itself connects the episodes into a building pattern that is still early”。在电话中,管理层没有说“这些事件表明我们正在进入一个更大的趋势”之类的。他们只是说“we have delivered substantial progress”。所以我认为答案是否定的。但让我们再仔细看:在ProTmune部分,Chris说“we believe that with the implementation of this protocol amendment we are well-positioned to rapidly deliver robust results that can enable confident decision-making and potentially s
Fate Therapeutics, Inc.
The call grade, management's tone measured against 177,437 other calls, what changed since the quarter before, and every one of the 500 checks.
This is the current report. Unlock its call read, expected move size, and all 500 answers.
- Are there more than eight analyst questioners?
- Does the operator announce more than five questioners?
- Does the operator announce more than ten questioners in the Q&A?
- Is there a questioner from an investment bank other than the first three analysts who ask questions?
30 markers, measured against 177,437 calls
Language counted straight from the transcript, behaviour read by the 500 checks, tone above. The band is the middle half of every call we have graded; a flag means this call sits outside it.
All 500 AI checks
Q4 2023 · 500 checks
Every answer is below. Open any check to see what its YES or NO means.
YES Does an executive answer a question by describing a process rather than an outcome?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a question the executive answers with a question back to the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone compare the company to an unnamed "competitor" or "peer" rather than naming it?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use "historically" or "traditionally" while defending a current practice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a departure, transition, or role change mentioned only in passing without a thank-you or tribute?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference a private conversation ("as I told...", "as we discussed offline")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the transcript contain the phrase "next question" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question spanning more than five sentences?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a question containing multiple sub-questions (three or more)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO answer a question personally after another executive initially responds?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the phrase "if you look at" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst preface a question by summarizing the company's stated results?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "obviously" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "guidance" in the same sentence as a specific number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst say "congrats" or "congratulations" to management?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "scale" or "scaling" used as a verb?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question beginning with a number ("two questions", "three quick ones")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst say "thank you" before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst name two or more executives when asking their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "outperform," "outperformance," or "beat" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "the environment" when describing market conditions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "Great question," "Thanks," or "Appreciate"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "adjusted" or "non-GAAP" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "with that" as a transition phrase?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a comparable basis" or "adjusted for"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "moving to" or "turning to" when changing topics?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "over to you" or "I'll turn it over"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "operator" aloud during the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone repeat the same stock phrase three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the phrase "as you know" to introduce a claim?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker apologize without attaching a fix to the apology?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the call end without any closing statement from the CEO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a request to move the call along or to the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive answer a question with another question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive mention the weather?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a negotiation currently in progress?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive describe a competitor with anything resembling respect?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator announce more than ten questioners in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "kind of" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question include the word "color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO deliver the opening remarks rather than the CFO or IR head?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "if I may" or "if you don't mind"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive's first sentence include the word "revenue"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the word "clarification" or "clarify" in a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the phrase "color on" or "some color"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator use the phrase "our final question" before closing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "let me" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "aggressive" or "aggressively" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask a question referencing "the puts and takes"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "to be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst's question include a compliment followed by "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the word "sequential" or "sequentially" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "with that" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "for the benefit of" or "just to remind" when restating context?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "early days"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "journey" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the speaker describe a strategy as "disciplined" without describing any trade-off?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there an apology offered to a specific analyst by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "to be honest" or "frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone promise to "follow up" or "take that offline" and fail to commit to when?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone on the call interrupt a colleague mid-sentence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does someone use a personal anecdote rather than a metric to justify confidence?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "question" appear in the operator's speech more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "growth" appear at least ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a couple of"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation or buybacks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "strong" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "we're seeing" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the word "confident" or "confidence" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "record" appear at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "team" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management promise to follow up or take a question offline?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we're excited about" or "we're pleased with"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Do two or more analysts from the same firm ask questions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "moving forward" or "go forward"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management mention a specific number of stores, locations, or markets?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the word "folks"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "we believe"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator use the phrase "next question" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention a specific percentage figure in their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "quarter" appear in at least ten questions or answers during the Q&A?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does at least one analyst ask a question about margins or costs?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer the majority of analyst questions personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question phrased as "Can you talk about" or "Can you speak to"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO speak during the Q&A portion at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question reference a specific quarter (e.g., "fourth quarter") by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator interrupt the Q&A to announce time is limited or that this will be the last question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question beginning with "just" (e.g., "just curious")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific dollar amount or number stated in the prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question begin with the words "can you" or "could you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the phrase "if you look at" during the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO answer at least one question without the CEO speaking first?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing an explicit comparison to a competitor company?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "moving on" or "next question" come from the operator?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask about capital allocation (capex, buybacks, M&A, or dividends) in one question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "color" appear (e.g., "add some color") in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "guidance" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question contain the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "I think" at least three times within a single answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive's answer exceed 300 words in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO answer the first analyst question personally?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "obviously" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain the word "margin" more than ten times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive begin an answer with "So" as the first word?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "if I may" or "if I could" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "let me" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any question contain the word "specifically"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the word "momentum" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management mention "margin" or "margins" in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "definitely" used by any speaker?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "robust" to describe demand, growth, or the pipeline?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "leverage" as a verb at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive use the word "team" when referring to employees?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive say "that said" or "having said that" to introduce a caveat?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "great question" at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we remain confident" or "we are confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any executive say "thank you" immediately after finishing an answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive cite a specific dollar figure greater than one billion?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question contain the word "curious"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a specific prior quarter by name (e.g., "last quarter")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "obviously" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a follow-up in the same turn after their first answer?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about a specific geographic region or market?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst ask a question that includes the phrase "long term" or "long-term"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "margin" or "margins" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "opportunity" or "opportunities" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "we'll come back to that" or defer an answer to a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" three or more times in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO use the phrase "free cash flow" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO mention at least one specific customer segment by name (e.g., "enterprise")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "take your question" or "take the question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst introduce themselves by name before asking their first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "including" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management reference "the macro environment" or "macroeconomic" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive reference "our team" or "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the operator announce more than one analyst from the same firm?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any prepared remark mention "headwinds" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "with that, I'll turn it over"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO use the phrase "capital allocation"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive decline to answer, citing that something will come later or is not disclosed?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a two-part question containing the word "but"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone ask a follow-up question in the same turn after their first question is answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone answer "yes" or "no" as the first word of a response?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive use the phrase "if you look at" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst begin their question with "Hi" or "Hello" as a greeting?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we are excited about" without naming a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a peer company's results or valuation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "just to clarify" or "just to be clear"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwind" or "headwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "momentum"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "investments" appear in the context of margins or costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention "FX" or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "efficiency" or "productivity" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank the executives or congratulate them before asking a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive say "great question" or "thanks for the question"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "as we said last quarter" or reference a prior call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "levers" when discussing actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management thank analysts by name at any point after a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we'll take that offline" or offer to follow up after the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "committed" regarding a target?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks mention "macro" or "macroeconomic"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "the vast majority"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "temporary" or "transitory" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is an analyst's question answered with "great question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a questioner from an investment bank other than the first three analysts who ask questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question that includes a reference to a specific dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "thank you" at least ten times across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you for taking my question" or "thanks for taking my question" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst's first sentence contain a compliment or thanks before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO present in both the prepared remarks and the Q&A portion of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally deliver the closing remarks of the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO's prepared remarks contain the word "team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "moving on" or "with that" to transition between topics?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "in terms of" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO First-person singular ("I believe," "I think") used more by the CFO than the CEO.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES A single question receives answers from two different executives.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES A hedge word ("maybe," "sort of") appears inside a direct quantitative claim.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the word "obviously"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in both prepared remarks and the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any executive defer a question to another executive by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Someone uses the word "honestly," "frankly," or "to be clear."
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "ecosystem" or "platform" without a number attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the transcript contain the word "certainly" three or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone begin an answer by restating or paraphrasing the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst reference a competitor by name during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker say "let me" at least twice in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES The transcript contains an apology unrelated to financial results.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The word "challenge" is spoken more often than "opportunity."
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "seasonality" or "seasonal" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO The phrase "as you know" appears at least twice.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use the word "challenge" or "challenges" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone mention "weather" as a factor affecting results?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "thank you" to the analyst before answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "great question" or similar praise of a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO The final question is answered noticeably shorter than the opening ones.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we remain" followed by a verb (e.g., "we remain committed")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive cite a conversation with a customer that has no verifiable specificity (unnamed, undated, unquantified)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a sentence that begins with "What I would say is"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any question mention a specific percentage or dollar figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more questions than any other executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator say "our final question" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "opportunity" or "opportunities" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "leverage" appear as a verb at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's first name get used by an executive when thanking them?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator announce more than five questioners?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are there more than ten analyst questions in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator use the phrase "our next question comes from" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are the CEO's prepared remarks longer than the CFO's, judged by speaker turns on the transcript page?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management say "we are not going to comment on" or equivalent refusal language?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Executive corrects an analyst's premise.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared section exceed the CEO's in number of paragraphs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO personally answer more than half of the analyst questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst mention the word "margin" in their first question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Executive uses the word "excited" more than twice.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a multi-part question containing three or more distinct questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a two-part question signaled by "and also" or "and secondly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst begin with a compliment, such as "great quarter" or "congrats"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we said" when recalling prior statements?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst begin their turn with "thanks" or "thank you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "tailwind" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "synergies" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst address a question to two or more executives by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "we feel" rather than "we believe" or "we think"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "capital" appear in at least three different speakers' turns?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive use the phrase "over time" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "as I mentioned" or "as we said" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO open the call before any analyst questions by mentioning the macro environment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "we are pleased" or "we're excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "leverage" (financial or metaphorical)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management before asking their question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "automation" or "productivity" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "uncertainty" or "uncertainties" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "year over year" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "leverage" or "leveraging" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Currency headwinds mentioned unprompted.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the phrase "a number of" used at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "best-in-class" or "industry-leading"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "momentum" appear at least twice in prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "on a constant currency basis" or similar currency adjustment used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's question include the phrase "just to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "the team" appear at least twice in management remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "so clearly" or "quite frankly"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the phrase "we believe" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Speaker says "we don't guide" on anything.
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CFO use the word "quarter" at least ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "thank you" more than five times in total?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" or "macroeconomic" appear at least twice in the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "typically" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive state they will "come back to" a question or follow up later?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts for their questions at any point during Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Speaker admits being surprised by anything.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "going forward" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "stability" or "stable" when describing demand?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Word "normal" used about demand.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "stay tuned" or "more to come"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management describe a cost program, restructuring, or efficiency initiative by a proper name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO's prepared section mention interest expense by name or figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "volatility" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Executive mentions a hobby or personal anecdote.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "pipeline" appear without a dollar figure attached?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "the macro" or "macro environment" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "our team" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "great question" or "good question" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "we remain" followed by an adjective?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management thank analysts by name when responding?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "flexibility" or "flexible" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "takeaway," "take out," or "take rate"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Analyst compliments the team before asking a question.
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker use "we're" where "we are" could substitute, more than twenty times overall?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst reference the CEO or CFO by first name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "obviously" at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone use the word "pipeline" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "moving on" or "let me turn it over" during prepared remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask a question starting with "just"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "headwind" or "headwinds" more than once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst use the phrase "to clarify"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive use the phrase "year over year" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive cite a conversation with a customer, partner, or employee as evidence?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question go to a named executive other than the CEO or CFO?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "to be clear" or "let me be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone mention a competitor by name without being prompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a question that management declines to answer directly, citing timing or disclosure constraints?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any question explicitly reference the company's prior guidance or outlook?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "next question" or does the operator use the word "final" before the last question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "invest" or "investment" appear at least five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CFO handle a strategic question instead of a financial one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst flatter management within their first sentence of speaking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst ask two questions when told to ask only one?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "underlying" to modify a business metric?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "excited" or "pleased" at least twice in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in the prepared remarks (not just Q&A)?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "margin" used with a number attached (e.g., "400 basis points")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript contain the word "record" preceding a noun (e.g., "record margin")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive answer a question by citing a competitor's actions?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "macro" or "macroeconomic" appear in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenges" appear more than once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO begin an answer with "look" or "listen"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "inflation" appear anywhere in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is there a pause or silence acknowledged on the call ("I think we lost you")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an executive name a specific competitor during the call?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenges" appear at least three times in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "we don't break that out" in response to a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a metric as "noisy" or "lumpy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive mention a specific number of percentage points when discussing market share?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does a speaker correct a figure they themselves just stated?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO refer to a competitor by name rather than "competition" or "peers"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the CEO mention their own tenure or years of experience unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "the team" when taking ownership would be natural?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone blame weather, holidays, or calendar quirks unprompted?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone cite a personal anecdote involving a customer conversation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "a little bit"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is the CFO the speaker for at least one analyst question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "guidance" appear in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "we're excited" or "we are excited"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "dividend" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "invest" or "investment" used more than twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "invest" or "investment" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone cite a percentage of revenue from a specific segment?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenge" or "challenging" appear at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone describe cutting discretionary spending like travel or hiring?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "year over year" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "liquidity" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript mention refinancing, maturity dates, or debt coming due?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention selling assets, real estate, or equipment to raise cash?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone reference "the macro" or "macro environment"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "our customers" rather than naming a customer?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the transcript include a question about interest expense or debt service?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "working capital" appear in a context other than a seasonality excuse?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management thank analysts at any point?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone reference borrowing from a bank or drawing on a credit facility?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "cost" appear in the first ten sentences of prepared remarks?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive say "we remain confident" or similar?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone mention covenants, amendments to loan documents, or lender conversations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "with that" or "that said" to pivot?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive open their first answer by thanking the analyst?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include the word "capex" or "cash flow"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "headline" or "headwinds" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "core" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst's turn contain the word "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst ask a question containing "how" and also "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "as we mentioned" or "as I mentioned" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Are there more than eight analyst questioners?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst's question include a percentage figure?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any analyst's question contain the word "guidance"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CFO's prepared remarks exceed 1,000 words?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any speaker say "if you look at"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO personally answer the first question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "tailwind" or "tailwinds"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "balance sheet" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CEO make closing remarks after the Q&A ends?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "structurally" or "secular"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "our next question" two or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the final questioner get an explicit closing acknowledgment from the operator ("last question" or similar)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "business as usual" or "as expected" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst preface a question with "quick" or "quickly"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive state a specific numeric percentage when answering a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone say "in terms of" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question that clearly annoyed the executive, visible in the reply's abruptness?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "guidance" appear in the Q&A section?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "strong" appear more than five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the phrase "thank you" appear more than ten times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does an analyst ask a question containing the word "margin"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "guidance" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the phrase "thank you" appear at least ten times anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an executive begin an answer by restating the analyst's name?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask about capital allocation or share repurchases?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "challenge" or "challenging" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "opportunity" or "opportunities" appear more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Is there a villain—market conditions, regulation, currency—that behaves consistently across the call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenging" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "certainly" appear at least once in management's answers?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a personal, warm, or congratulatory question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "capital" appear at least five times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst ask a question the prepared remarks already answered?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "quarter" appear at least twenty times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any single analyst ask more than two questions during the whole call?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "on a year-over-year basis" or "year over year" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "headwinds" or "tailwinds" used?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "margin" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "confidence" or "confident" spoken by any executive?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the phrase "call it" or "let's call it" before an estimate?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "going forward" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "coming back" or "circling back" to take a follow-up?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "inflation" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we believe" at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the word "robust"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker use the phrase "if you will" or "so to speak"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "appreciate" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone use the phrase "at the end of the day"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone tell a self-contained anecdote with a beginning, middle, and end?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the phrase "our team"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the transcript contain a silence, pause, or "we'll come back to that" that never resolves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone describe a customer, employee, or competitor as a named character with a motive?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive say "we're pleased" or "I'm pleased"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a moment of modesty—someone crediting luck or timing?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" or "exciting" used by management at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker say "just" five or more times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any question begin with "Can you" or "Could you"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "quick" or "quickly" appear in three or more analyst questions?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst ask for guidance on a metric management did not offer unprompted?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there a question about capital allocation (buybacks, M&A, debt, or dividends)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst use the word "clarify" or "clarification"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "obviously" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management refer to a prior call or prior quarter's commentary when answering?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone use the word "actually" at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive begin an answer with "Look," or "So,"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the word "challenging" or "challenges" appear at least three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the operator run out of queued questions and close early?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst apologize or preface with "sorry" before asking?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "excited" used by the CEO more than the word "confident"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any speaker use the phrase "the right" before a noun ("the right team," "the right decisions")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "guidance" appear more than five times in the transcript?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "tailwind" or "headwind" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst's question begin with a compliment or congratulation?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an analyst apologize before or during their question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Are there more questions about revenue than about costs?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "challenging" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the phrase "on a" four or more times total (e.g., "on a constant currency basis")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive answer begin with "Sure" or "Yes" followed by a comma?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "from a ... perspective" (e.g., "from a margin perspective")?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an executive say "we're not going to" in response to a question?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does management decline to answer by citing a future event ("we'll address that in..." or "at our upcoming...")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "quarter" appear at least 20 times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is there a mention of "FX," "currency," or "foreign exchange"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "that's right" or "that's correct" to an analyst?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "leverage" appear at least twice?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is the word "leverage" used at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the word "headwinds" at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "great question" or thank the analyst before answering?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone attribute results to "the team" rather than to strategy?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any speaker say "going forward"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst begin their question with "congratulations"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does an analyst thank management at the end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does anyone describe the future with "We believe" more than "We expect"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does a speaker say "normal" or "normalized" about conditions that predate any disruption mentioned?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Is the word "momentum" used without a stated metric attached to it?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "macro" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does management use the word "solid" at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Is there an analogy to a machine, engine, or flywheel?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "visibility" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "base case" or "scenario" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does anyone say "we take that seriously" or "we're very focused on"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the phrase "to your point" or "as you mentioned" used at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the operator say "thank you" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management mention a specific competitor by name?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management say "the team" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "fundamentally" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the phrase "ahead of" precede any mention of guidance or expectations?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does management use the phrase "on a year-over-year basis"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any single speaker say "right?" as a tag question at least once?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "on a consistent basis" or "consistently"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does a speaker begin a sentence with "To be honest" or "To be clear"?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does management use the phrase "strategic" at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker describe a business unit as "healthy"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "fundamentals"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "resilient" or "resilience" appear?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the operator mention a queue or "next question" more than three times?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does any analyst ask a follow-up after their initial answer ("follow-up", "second one", "just one more")?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does any analyst ask a question containing the word "why"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does anyone say "if you look at" before citing a number?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "last question" or "final question" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "clearly" appear anywhere in the transcript?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does the CEO speak first among named executives in the Q&A?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the word "headwind" or "headwinds" appear at least twice?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the CFO mention a specific percentage greater than ten?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the phrase "going forward" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "team" appear at least three times?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does the word "confident" appear in any executive's remarks?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
YES Does an analyst thank management at the start or end of their turn?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does the CEO use the word "incredibly" at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
YES Does any executive use the word "team" to refer to company personnel?
The model found enough evidence in the earnings transcript to mark this exact condition as present.
NO Does anyone say "to your point" when answering a question?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive say "with that" to transition between speakers or topics?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "transformation" or "transformational" appear?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker say "moving on" or "next question" themselves?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any speaker use the word "hedging" or say "to hedge"?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any analyst identify themselves with a two-part introduction (name and firm)?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does the word "talent" appear at least once?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is the word "capacity" used more often about factories than about people?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does an executive confess to having too much of something physical somewhere?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Is a supplier or vendor mentioned by name at any point?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
NO Does any executive blame weather, season, or geography for a shipment or delivery issue?
The model did not find enough evidence in the earnings transcript to confirm this exact condition. NO means “not detected,” not necessarily “disproved.”
Archived AI reasoning
Earlier Artul research experiments on FATE calls. Open a question to read the model's original reasoning.
NO Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
Original model output from the research archive. It may be verbose or include the model's working notes.
NO Promise already turning into fact: management shows the thing it told investors was coming is now measurably arriving, a
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need identify pattern: prior expectation, current confirmation, still early. Let's examine. Company Fate Therapeutics. Developments: ProTmune clinical trial, FATE-NK100 IND, ToleraCyte, iPSC platform. Need see if management points to growth-bearing development previously told investors to expect and now arriving at/beyond pace, while still early. Look for phrases: "As Scott mentioned..." "we have now..." "over past several months we have delivered substantial progress..." "we recently amended..." "enrollment is now open under enhanced protocol." "We expect to initiate randomized controlled Phase 2 stage in first quarter 2017." "After holding successful pre-IND meeting... FATE-NK100 has now progressed to IND filing." "We've also held successful pre-IND meeting... ToleraCyte." "We have now initiated clinical translation of our first off-the-shelf product candidate..." "we plan to submit preclinical briefing package to FDA in coming weeks." Question asks: Does management point to a growth-bearing development in its business that IT HAD PREVIOUSLY TOLD INVESTORS TO EXPECT — and demonstrate, with real current-period activity, that this development is NOW ACTUALLY ARRIVING at or beyond pace, while ALSO conveying still early? Need identify if management refers back to prior expectation. The transcript doesn't explicitly quote previous quarters. But management may refer to "we have now..." "as we said..."? Let's search. Scott: "Over the past several months we have delivered substantial progress and intensified our clinical commitment to each of our programs. Seven U.S. clinical sites are now open for enrollment in our Phase 1/2 PROTECT clinical trial of ProTmune." That's current. "We believe ProTmune has potential..." "Over the past several months the U.S. Food and Drug Administration granted fast-track and Orphan Drug designations..." "Given favorable recognition... we recently amended our clinical trial protocol to blind both investigators and subjects... While this has initially delayed enrollment in Phase I stage, enrollment is now open under this enhanced protocol. We expect to initiate randomized controlled Phase 2 stage in first quarter 2017." This is a development. Did they previously tell investors to expect? Not explicitly in transcript. But maybe "we have now progressed to IND filing" after pre-IND meeting.
NO Deliberately different by design: management explains how the company operates unlike its industry's standard playbook,
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer only YES or NO. Need evaluate transcript. Need determine if management describes company as deliberately operating differently from standard industry way, specific chosen difference, and credits that difference as driver of current business results. Transcript: Fate Therapeutics developing cellular immunotherapics, pioneering use of engineered pluripotent cell lines to develop off-the-shelf cell therapy products, revolutionary approach that moves beyond reliance on patient source cells and enables renewable, standardized scalable manufacture. This is a chosen departure from industry normal way? They say "Cellular immunotherapy undergoing clinical investigation today are patient specific and typically require harvesting, engineering, expansion and reintroduction of each individual patient cells. In contrast, we are developing a disruptive approach to this current clinical practice. Similar to master cell lines used for manufacture of monoclonal antibodies engineered pluripotent cell lines are highly stable and have potential to serve as renewable self source for consistent manufacture of clonal populations of effector cells." That is a specific chosen difference in how company operates vs industry normal. But is it paying off in current real business? They have IND filed for FATE-NK100? Actually FATE-NK100 is donor-derived NK cells, not iPSC. The iPSC platform is preclinical, not yet clinical. They say "We have now initiated clinical translation of our first off-the-shelf product candidate for a more induced pluripotent cell platform and engineered high affinity CD 16 natural killer cell." But they plan to submit briefing package to FDA in coming weeks. No current results credited to that difference. They have partnership with Memorial Sloan-Kettering, licensed IP. But no current business results from iPSC platform. They mention "We have the opportunity to be the first group to ever advance an engineer -induced pluripotent cell line derived cancer immunotherapy into clinical development" - future. Other possible differences? ProTmune? They describe ProTmune as next generation graft, but not necessarily different from industry? They mention blinding, etc. Not a chosen departure from industry normal way? Maybe they are developing off-the-shelf vs patient-specific. But current results? They have IND filed for FATE-NK100, but that's not iPSC.
NO Questions aim low, answers land high: the dialogue keeps correcting expectations upward with facts already in hand
Original model output from the research archive. It may be verbose or include the model's working notes.
The question asks whether there is a recurring mismatch in level between what questioners assume and what management reports, with the mismatch running upward. I need to analyze the Q&A portion of the transcript. Let me look at the Q&A exchanges: 1. First question from Do Kim (BMO): Asks about whether the randomized Phase 2 data will be the basis for filing, and whether they expect to run another trial. Management says they believe the study has potential to support accelerated registration. Then asks about FDA feedback on the protocol revision - management says they haven't discussed with FDA but the study design is typically supportive. Then asks about increasing target enrollment - management says they are continuing to ramp sites. Then asks about the bar for NK cell drug in AML - management says they expect response rates in the 30-50% range based on prior experience, and will look at biomarkers. 2. Second question from unidentified (Wells Fargo): Asks about sham treatment for control, and about whether they need to add CMV patients to meet statistical criteria. Management explains stratification and maintaining minimum CMV positive patients. Then asks about moving into mismatched setting - management says they will think about it, mentions haploidentical transplantation as an area of interest. Then asks about NK cell manufacturing and checkpoint resistance durability - management says first clinical experience will be single donor/single patient, and they will explore multiple doses. 3. Third question from Mark Breidenbach (Roth Capital): Asks about whether blinding is really necessary for GvHD assessment given it's fairly objective. Management explains there are subjective components (skin involvement, diarrhea reporting). Then asks about timing of Phase 1 data - management says they will report as they clear safety hurdle. Then asks about Juno collaboration and whether they're getting closer to first target - management says they don't have visibility into Juno's decision-making but have delivered data packages. 4. Fourth question from Ren Benjamin (Raymond James): Asks about what would constitute statistically significant benefit - management explains p value less than 0.05 and gives example of reducing GvHD from 50% to 20%. Then asks about enrollment timing - management says they were screening while amendment was processing but didn't enroll.
NO Fresh problems of growth: the call's frictions are about handling more business, not finding it
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if difficulties discussed are predominantly problems of growth vs weakness/decline/demand etc. Need use only transcript. We need parse call. Company Fate Therapeutics. Discusses progress. Potential difficulties/pains/challenges: - ProTmune PROTECT trial: protocol amendment to blind investigators/subjects, expanded eligibility. "While this has initially delayed enrollment in Phase I stage, enrollment is now open under enhanced protocol." They implemented modifications, processing/implementation delayed enrollment. This is a self-imposed change to enhance registration, not growth friction? It is a friction due to expanding trial? They are opening sites, screening at seven, engaging more sites. The delay is from protocol amendment, not growth. But they are expanding trial. Need see if management discusses difficulties as growing pains? They mention "challenges" in blinding due to four-hour on-site manufacturing process, overcame. "We recognized there would be challenges, the blinding, given that we have a four-hour on-site manufacturing process for ProTmune and this is obviously not applicable to the control standard mobilized peripheral blood graft. So in working with the cell processing units and our investigators, we recently worked to overcome this challenge with respect to blinding..." This is operational challenge of trial design, not growth. - FATE-NK100 IND filed, preparing first-in-human. No difficulties. - ToleraCyte pre-IND positive, formulating protocol. - iPSC platform, engaging FDA. - Financial: net loss increased, R&D expenses increased due to third-party service provider fees to support clinical development and research activities, personnel expenses from additional headcount. This is growth-related? They are spending more due to expanding activities. But is that a "difficulty/pain" discussed? They report financial results, not necessarily difficulties. The question asks "when management discusses the difficulties, pains, or challenges the company is currently dealing with, are those difficulties predominantly PROBLEMS OF GROWTH..." Need identify if any difficulties discussed. They mention "challenges" in blinding, "initial delay" in enrollment, "hard work and pace" etc. Also "substantial unmet need" not company difficulty. "There is substantial unmet need in HCT" not company.
NO Spending like a bigger company on purpose: current results carry the cost of an expansion aimed at demand management say
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management acknowledges that current results are being weighed down by an expansion already undertaken, and if they justify it by pointing to demand that is already real. Let's analyze the transcript. The company is Fate Therapeutics. They are a biotech with clinical programs. The financial results show a net loss of $8.7 million vs $6.9 million last year. R&D expenses increased from $5M to $6.8M, attributed to third-party service provider fees to support clinical development of ProTmune and research activities, and personnel expenses due to additional headcount. G&A increased due to IP-related expenses. Is this an expansion? They are advancing clinical trials, opening sites, filing INDs, etc. But is there a specific expansion that is costing them and weighing on current results? They mention "we have intensified our clinical commitment" and "bolstered our ability" etc. But they don't explicitly say that these costs are weighing down profitability or that they are carrying extra capacity. They just report increased expenses. They don't frame it as a deliberate expansion that is depressing margins. They don't mention any specific expansion like building a facility or hiring ahead of revenue. The increased R&D is for clinical trials and research, which is normal for a biotech. They don't say "we are investing in expansion that will pay off later" in a way that acknowledges current results are understated. They don't point to demand that is already real. They talk about clinical trial enrollment, but that's not demand in a commercial sense. They have partnerships, but that's not new demand. They don't say "we have orders" or "we are seeing demand." So it's a NO. The question asks: "does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken" and "does management justify carrying that burden by pointing to demand or business that it says is ALREADY REAL". In the transcript, management does not explicitly say that the increased expenses are weighing down results. They just report the numbers. They don't say "we are investing heavily in expansion and that's why our losses are higher." They don't frame it as a burden. They also don't point to any real demand. They talk about clinical progress, but that's not commercial demand.
NO The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks: Is there a specific negative outcome that investors/analysts/market have been worried about for this company, and does management push back with already-observed evidence showing it's not materializing? Let's examine the transcript. The company is Fate Therapeutics, a biotech. They discuss ProTmune, FATE-NK100, ToleraCyte, and iPSC platform. Analysts ask questions. Do they probe a specific fear? Let's see. First analyst (Do Kim) asks about the PROTECT study, whether the randomized Phase 2 data will be basis for filing, and about enrollment. They ask about feedback from FDA. Then about adaptive NK cell drug for AML, what bar for continuing. Second analyst (Jim Birchenough) asks about PROTECT trial, sham treatment, patient numbers, stratification, and then about NK program. Third analyst (Mark Breidenbach) asks about PROTECT study, blinding necessity, and about Juno collaboration. Fourth analyst (Ren Benjamin) asks about blinding, statistical significance, and about NK100 and iPSC. Is there a specific fear? Possibly the fear that the PROTECT study might not support accelerated registration, or that enrollment is delayed. But management addresses that by saying they amended protocol to blind, and that they believe it can support accelerated registration. They also mention that enrollment is now open. But is that a fear that analysts are probing? They ask about the design, but not necessarily a fear of a negative outcome. They ask about whether the study will be basis for filing, and management says they believe it can. That's more of a question about strategy. Another possible fear: that the company's lead product ProTmune might not show efficacy, or that the trial might be delayed. But management says they are confident. Also, there is a mention of the Juno collaboration. Analyst asks if Juno might announce first target. Management says they don't have visibility into Juno's decisions, but they have active collaboration. That's not a fear. What about the fear that the iPSC platform might not get to clinic? Management says they will submit briefing package. I don't see a specific negative outcome that analysts are worried about. The questions are more about trial design, timing, and strategy. There is no mention of a feared event like losing a major customer, demand falling, etc.
NO Escalation cadence: management recounts upgrading its own response multiple times in quick succession as the same positi
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the transcript shows a pattern of repeated same-direction upgrades in response to positive business strength. Let's analyze. The question asks: Does management recount that, within the recent period, the company responded to a positive development more than once in quick succession? That is, a sequence of taking a real step, finding it overtaken by continued strength, and stepping up again. We need to look for a positive force already acting on the business, at least two distinct sequential upgrades already taken, and management presenting this cadence as the period's story with the force still running. Let's read the transcript carefully. The call is about Fate Therapeutics. They discuss ProTmune, FATE-NK100, ToleraCyte, and iPSC platform. Key points: - ProTmune: They amended the clinical trial protocol to blind both investigators and subjects. This was a change to facilitate accelerated registration. They also expanded subject eligibility to include MDS and CML, and CMV negative subjects. This is a protocol amendment. They say "While this has initially delayed enrollment in the Phase I stage, enrollment is now open under this enhanced protocol." They expect to initiate a randomized controlled Phase 2 stage in Q1 2017. This seems like a single amendment, not multiple sequential upgrades. - FATE-NK100: IND filed, planning to initiate Phase 1 in early 2017. No mention of multiple upgrades. - ToleraCyte: Pre-IND meeting, planning to formulate study protocol. No multiple upgrades. - iPSC platform: They plan to submit a preclinical briefing package to FDA. No multiple upgrades. - Partnership with Memorial Sloan-Kettering: Formed a multiyear partnership. That's a single event. Now, is there any pattern of repeated same-direction upgrades? The question specifically asks about responding to a positive development more than once in quick succession. For example, adding capacity, then adding more again. In the transcript, I see no such pattern. The company is making progress on multiple programs, but each program seems to have a single step forward. For ProTmune, they amended the protocol once. For FATE-NK100, they filed an IND. For ToleraCyte, they had a pre-IND meeting. There is no description of a force like "demand is exceeding our expectations, so we added more sites, and then we added even more sites" or something like that.
NO Center of attention has moved to the newest working thing: management's energy is disproportionately on a small but alre
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management devotes a clearly disproportionate share of energy, enthusiasm, and detail to one identifiable part of the business that is still a minority of overall results today, and whether that part is described as already producing real, current business (revenue, orders, customers, etc.) with management treating it as the main driver. The transcript is about Fate Therapeutics. The company has several programs: ProTmune (a clinical product for HCT), FATE-NK100 (NK cell therapy), ToleraCyte (for autoimmune), and an iPSC platform (engineered pluripotent cell lines). The company is a biotech with no approved products, so all are in development. The call discusses progress: ProTmune is in Phase 1/2 clinical trial, FATE-NK100 has IND filed, ToleraCyte pre-IND, iPSC platform in preclinical. Management discusses all programs. Which one gets the most attention? The call starts with ProTmune, then FATE-NK100, then ToleraCyte, then iPSC. But the question asks: is there a specific piece that is smaller today than the established base, yet receives richest discussion, and is described as already producing real current business? Since the company has no revenue from products, all are pre-revenue. The only revenue is from a collaboration with Juno Therapeutics, which is mentioned as $1 million in revenue. That is the established base? Actually, the company's revenue is from research collaboration with Juno, not from any product. The programs are all in development. The question asks: "the favored part is described as ALREADY PRODUCING real, current business (actual revenue, orders, customers, volumes, openings, bookings, or deployments happening now)". In a biotech, clinical trials are not revenue. The only revenue is from Juno collaboration, which is not the focus. Management does not describe any product as producing revenue. They describe clinical progress, IND filings, etc. So none of the programs are producing current business in terms of revenue. They are all in development. The question might consider "openings" as in clinical sites open? But that's not business revenue. The question says "real, current business" meaning actual paying activity. In this context, the company has no product sales. So the answer is likely NO because the favored piece is not described as producing current business; it's still in clinical trials.
NO Secure base, several live doors: core not in question, multiple distinct expansion avenues already producing
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management speaks from secure settled core business not defending/fixing, and describes more than one distinct avenue of growth beyond core, each already real producing early results. Company Fate Therapeutics. Core? Lead product ProTmune for HCT. But is that core? They are clinical stage, no revenue from products. Revenue from Juno collaboration $1M. Core business? Maybe research collaboration with Juno? But management discusses ProTmune clinical development, FATE-NK100 IND, ToleraCyte, iPSC platform. Need identify "established main business" - perhaps ProTmune is lead clinical product but not commercial. The call is about progress. Is core "ProTmune" being defended? They discuss protocol amendments, enrollment delayed but now open. They are not defending weakness? They describe substantial progress. Base not in question? They have cash, etc. But "core business" for a biotech with no approved products? The question asks "secure, settled core business" - likely means existing operations. Management speaks from? They have revenue from Juno collaboration, but that's not core? Need parse. Question: "Using ONLY supplied earnings call transcript and no outside information: On this call, does management speak from a SECURE, SETTLED CORE BUSINESS — one it is plainly not defending, fixing, or fighting to keep — while ALSO describing MORE THAN ONE distinct avenue of additional growth beyond that core, where EACH avenue is already real and producing at least early results today?" Need answer YES when management's own words convey both halves. Need identify core and avenues. Management: Fate Therapeutics developing cellular immunotherapies, pioneering engineered pluripotent cell lines. Programs: ProTmune (lead clinical product), FATE-NK100 (IND filed), ToleraCyte (pre-IND), iPSC platform (preclinical), Juno collaboration (revenue). The "core" might be ProTmune? But they are not selling. The call is about progress across programs. They describe ProTmune as lead clinical product, but not "core business" in sense of revenue. They have revenue from Juno collaboration $1M. Is that core? They mention "strategic research collaboration with Juno Therapeutics" as revenue. But management doesn't discuss it as core business. They discuss R&D expenses. Maybe the "core" is the company's platform? Hmm.
NO Fresh change already executed, benefit mostly still ahead
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need evaluate transcript. Need identify specific change completed recently and benefit not yet appeared. Management mentions several: ProTmune protocol amendment blinding, expanded eligibility, enrollment open at seven sites, Phase 2 initiation Q1 2017. FATE-NK100 IND filed, clinical testing early 2017. ToleraCyte pre-IND. iPSC platform. Partnership with MSK. Need see if management points to specific change completed recently and says most benefit not yet in results. The question asks "on this call, does management point to a SPECIFIC CHANGE IN THE BUSINESS THAT THE COMPANY ITSELF COMPLETED OR PUT INTO EFFECT ONLY RECENTLY — within roughly last one or two quarters — and convey that MOST OF THE BENEFIT OF THAT CHANGE HAS NOT YET APPEARED in the results being reported, with benefit expected to show up over coming quarters?" Need parse. Management discusses ProTmune protocol amendment: "we recently amended our clinical trial protocol to blind both investigators and subjects... While this has initially delayed enrollment in Phase I stage, enrollment is now open under this enhanced protocol. We expect to initiate randomized controlled Phase 2 stage in first quarter 2017." This is a change completed recently (protocol amendment) and benefit? They say "we believe this addition greatly enhances our potential to pursue accelerated registration" and "well-positioned to rapidly deliver robust results" but not necessarily financial results. The question likely about business change with benefit in results. Could be FATE-NK100 IND filed, but no revenue. The company is biotech, results are losses. The change might be "IND filed" and "clinical testing expected to initiate early 2017" - benefit not yet appeared. But is that a "change in business" with payoff? The question asks "results being reported" - financial results. Management doesn't point to revenue from these. They point to progress. Need determine if they convey most benefit not yet appeared in reported results. They don't discuss financial impact. They discuss clinical milestones. The question likely wants YES if management identifies a recent completed change and says payoff ahead. But need be strict. Let's read transcript. Scott: "Over the past several months we have delivered substantial progress and intensified our clinical commitment to each of our programs. Seven U.S.
NO Quarter of firsts: the period's story is built from first-time events the company has never done before, now starting to
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if the call is built around first-time events that are genuine, already accomplished, and presented as beginnings with repetition forming. Let's analyze the transcript. Key events mentioned: 1. ProTmune clinical trial: They amended protocol to blind, opened enrollment at seven sites, plan to initiate Phase 2 in Q1 2017. This is not a first-time event in the sense of a product launch; it's a clinical trial progress. But is it a first? They have been running trials before. The amendment is a change, not a first. 2. FATE-NK100: IND filed, first in human testing planned. This is a first-time event: "an IND has now been filed" and "first in human testing is underway" - actually they say "preparation for first in human testing is underway" and "clinical testing ... is expected to initiate in early 2017". So the IND filing is a first, but the actual clinical testing hasn't started yet. The IND filing is a regulatory milestone, not a commercial or operational first. But it is a first for the company. 3. ToleraCyte: pre-IND meeting with FDA, positive outcome, planning first in human trial. Again, a first but still in planning. 4. Engineered iPSC-derived NK cells: They plan to submit a briefing package to FDA, and they have a partnership with Memorial Sloan-Kettering. They say "We have the opportunity to be the first group to ever advance an engineered induced pluripotent cell line derived cancer immunotherapy into clinical development" - but that's future, not yet done. 5. The partnership with Memorial Sloan-Kettering is a new collaboration, but not a first-time event in terms of product. Now, the question asks: "Is management's account of the just-reported period built substantially around FIRST-TIME EVENTS — real things the company actually did or achieved in or around this period that, in management's own telling, the company had NEVER DONE BEFORE — with management treating these firsts not as curiosities but as the OPENING INSTANCES of activity that is now beginning to repeat or scale?" We need to see if there are at least two distinct first-time events that are already accomplished and are presented as beginnings with repetition forming. Let's list what they actually did in the period: - They amended the ProTmune protocol to blind, and opened enrollment at seven sites. That's not a first-time event; they had sites before.
NO Story upgraded mid-call: management spontaneously tops its own prepared version with fresher or bigger facts
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management spontaneously upgrades its own story relative to its prepared version during the Q&A or unscripted parts. The prepared remarks are the initial statements by Scott, Chris, Dan. Then Q&A follows. We need to see if any unscripted comments reveal positive developments beyond what was in the prepared remarks. Key points from prepared remarks: - ProTmune: protocol amended to blind, enrollment open at 7 sites, Phase 2 expected Q1 2017. - FATE-NK100: IND filed, clinical testing expected early 2017. - ToleraCyte: pre-IND meeting positive, formulating study. - iPSC platform: planning to submit briefing package to FDA in coming weeks. - Partnership with MSK. Now in Q&A, we need to see if management volunteers any new, concrete, positive developments that are fresher or bigger than the prepared version. First question from Do Kim: asks about intention for Phase 2 data as basis for filing. Scott says they believe it's potential, and they made changes to enable accelerated registration. He mentions they overcame challenges with blinding. This is essentially restating the prepared remarks, not new. Second question from Jim Birchenough: asks about sham control, stratification, etc. Chris answers about stratification and maintaining minimum CMV positive patients. That's a detail but not necessarily an upgrade. Then asks about next steps for ProTmune, Scott mentions haploidentical transplantation as an area of interest. That's a future plan, not a current development. Third question from Mark Breidenbach: asks about blinding necessity, and timing of Phase 1 data. Chris explains bias in GvHD assessment. Scott says they will report Phase 1 data as they clear safety hurdle. That's not new. Then asks about Juno collaboration, Scott says they have active collaboration, delivered data packages. That's not new. Fourth question from Ren Benjamin: asks about statistical significance, Chris explains simulations. Then asks about ProHema, Scott says fundamentally different. Then asks about NK100 study design, Scott says 10-20 patients, updates at conferences. That's not new. Then asks about combination with antibodies, Scott talks about quadrants, but that's general. Then asks about ToleraCyte and iPSC IND timing, Scott says they will submit briefing package in coming weeks, and for ToleraCyte they have clear path. That's restating.
NO Numbers are lagging the physical build: management points to something already finished or nearly finished that has not
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need analyze transcript. Need determine if management points to something already finished built/acquired/put in place but not yet earning/running/just switched on. Need use only transcript. Let's parse. Company Fate Therapeutics. Programs: ProTmune clinical trial, FATE-NK100 IND filed, ToleraCyte pre-IND, iPSC platform. Need identify completed thing not yet contributing. Potential: FATE-NK100 IND filed, first-in-human testing planned early 2017. Is that "finished building" product? IND filed, not yet earning/running. But is it a real completed piece? They have product candidate produced, preclinical data, IND filed. Not yet launched. But is it "built, delivered, completed but not yet open"? Maybe yes? Need careful. Question asks: "does management point to something the company has ALREADY FINISHED BUILDING, ACQUIRING, OR PUTTING IN PLACE — but which is NOT YET EARNING, NOT YET RUNNING, OR ONLY JUST BEING SWITCHED ON — such that a real, completed piece of the company is currently sitting idle, dark, unopened, unstaffed, uncertified, or otherwise not yet contributing to the results being reported?" Need answer YES when management's own words convey one coherent situation: company has already spent money and done work, thing physically/contractually exists now, and earning life has not started yet. Examples include product/platform/formulation finished and ready but not yet launched/released/generally available. In transcript, FATE-NK100: "IND has now been filed and preparation for first in human testing is underway." "FATE-NK100 has now progressed to IND filing." "clinical testing ... expected to initiate in early 2017." This is a product candidate finished preclinical development, IND filed, not yet in clinical trials, not earning. But is it "completed" enough? It is a drug candidate, not yet approved, no revenue. But in biotech, clinical trial product not earning. The question likely about "idle asset" like built facility. Need infer from transcript. Also ProTmune: "seven U.S. clinical sites are now open for enrollment" in Phase 1/2 trial. "enrollment is now open under enhanced protocol." "We expect to initiate randomized controlled Phase 2 stage in first quarter 2017." This is a clinical trial, not earning. But is it "already finished building"? No, trial ongoing. ToleraCyte: "held successful pre-IND meeting...
NO Cornered by one hard problem: management describes the company organized around solving a specific difficulty most other
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO. Need evaluate transcript. Need determine if management describes company as organized around solving one particularly difficult problem that others haven't solved, routinely fail at, or avoid, and convey currently succeeding at that hard thing in real live operations. Need use only transcript. Need answer only YES or NO. Let's parse. Company Fate Therapeutics. Programs: ProTmune (hematopoietic cell transplant graft) clinical trial; FATE-NK100 natural killer cell immunotherapy IND filed; ToleraCyte; iPSC-derived off-the-shelf cell therapy. They emphasize "pioneering use of engineered pluripotent cell lines to develop off-the-shelf cell therapy products, revolutionary approach that moves beyond reliance on patient source cells and enables renewable, standardized and scalable manufacture." They say "disruptive approach to current clinical practice. Similar to master cell lines used for manufacture of monoclonal antibodies engineered pluripotent cell lines are highly stable and have potential to serve as renewable self source for consistent manufacture of clonal populations of effector cells for treatment of many thousands of patients. We have opportunity to be first group to ever advance an engineered iPSC line derived cancer immunotherapy into clinical development." They plan to submit briefing package to FDA. So not yet in clinic; future. Question asks: Does management describe company as organized around solving one particularly difficult problem that others in market have not solved, routinely fail at, or avoid altogether — and convey currently succeeding at that hard thing in real, live operations? Need identify if they name hard problem and demonstrate doing it now. The transcript includes "developing groundbreaking cellular immunotherapies and pioneering use of engineered pluripotent cell lines to develop off-the-shelf cell therapy products" - that's a hard thing? They describe "revolutionary approach" "disruptive" "first group to ever advance" but that is future, not current live operations. They have not yet advanced iPSC-derived into clinical development; they are preparing to discuss with FDA. So not "currently succeeding" in live operations for that. Other programs: ProTmune is in clinical trial, but is it solving a hard problem others haven't? They describe unmet need in HCT, GvHD, infections, relapse.
NO Reality beat their plan and they're leaning in: recent realized upside surprise, response underway, drivers still live
Original model output from the research archive. It may be verbose or include the model's working notes.
We need answer YES/NO based on transcript. Need identify if management recounts real recent period turned out better than company expected/planned, and already responding, cause still in effect. Let's parse transcript. Company Fate Therapeutics. Programs: ProTmune clinical trial, FATE-NK100 IND filed, ToleraCyte, iPSC platform. Need find any statement where management says actual events exceeded own prior expectation/plan/timeline, and response visible, cause still running. Potential candidates: - ProTmune: FDA granted fast-track and Orphan designations. They amended protocol to blind, expanded eligibility. Did they say this was better than expected? They say "Given favorable recognition from FDA and EMA... we recently amended..." Not explicitly surprise vs own expectation. They mention "While this has initially delayed enrollment... enrollment now open." No "ahead of expectations." - FATE-NK100: "After holding a successful pre-IND meeting with FDA in August FATE-NK100 has now progressed to IND filing." "We've also held a successful pre-IND meeting with FDA in October to support ToleraCyte." "FDA agreed..." Not necessarily surprise. - "We have now initiated clinical translation of our first off-the-shelf product candidate..." "We have the opportunity to be the first group to ever advance..." Not surprise. - Partnership with MSK: "formed multiyear partnership... aimed at leapfrogging..." Not surprise. - Financial results: net loss $8.7M vs $6.9M prior year, revenue $1M both. No better than expected. Need look for phrases like "ahead of expectations", "faster than planned", "exceeded". Search transcript. I see "substantial progress", "intensified", "accelerated". But no explicit "better than expected" vs own plan. There is "While this has initially delayed enrollment... enrollment is now open under enhanced protocol." That's a delay, not favorable surprise. "We expect to initiate randomized controlled Phase 2 stage in first quarter 2017." Previously maybe planned earlier? Not clear. Question asks: "does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favorable surprise in some visible way, with the cause of the surprise described as still in effect rather than finished?" Need answer YES only if all three parts.
NO Free option on their own operations: management describes a real capability it already owns that could serve a second, m
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to answer YES or NO based on the transcript. The question asks about a situation where something the company already owns and operates for existing business turns out useful for a second, much larger purpose, and they've begun turning that second use into real business without building new company. Let's analyze the transcript. The company is Fate Therapeutics, a biotech developing cellular immunotherapies. They have various programs: ProTmune, FATE-NK100, ToleraCyte, and an engineered iPSC platform (off-the-shelf). The question is about a specific phenomenon: existing capability used for a second larger purpose. Look for clues. The transcript mentions ProTmune is for HCT. FATE-NK100 is NK cell therapy. They have an induced pluripotent cell (iPSC) platform. They are using it to develop off-the-shelf therapies. Is there a second use? Possibly the iPSC platform was originally for something, now being used for cancer immunotherapy? But is it already converting? They have IND filed for NK100, but that's a different product. The question requires: (1) existing working capability not new build, (2) second use materially bigger, (3) already converting with numbers barely show it. Let's read carefully. Management talks about "engineering pluripotent cell lines to develop off-the-shelf cell therapy products" - this is a platform. They say "we are now using engineered pluripotent cell lines to generate clonal populations of NK cells and T cells..." This seems like a new initiative. They had a pre-IND meeting for an engineered iPSC-derived CD16 NK cell. They plan to submit briefing package. That is still early, not yet converting. Another possible: ProTmune itself? It's a product for HCT. There's also ToleraCyte for autoimmune. But that's separate. Maybe the key is the partnership with Memorial Sloan-Kettering for T cells derived from engineered pluripotent cell lines. That is a new collaboration. The question asks specifically about "SOMETHING THE COMPANY ALREADY OWNS AND ALREADY OPERATES FOR ITS EXISTING BUSINESS HAS TURNED OUT TO BE USEFUL FOR A SECOND, MUCH LARGER PURPOSE" - and they have begun turning that second use into real business. Is there a case? Possibly the iPSC platform was built for something, now being used for off-the-shelf therapies, but they are still in preclinical/IND stage. They haven't generated revenue from it.
NO Better business coming in than going out: management describes the quality of new intake visibly exceeding what it is re
Original model output from the research archive. It may be verbose or include the model's working notes.
We need to determine if management conveys that the business being taken in right now is of visibly higher quality than the business it is finishing, replacing, or letting run off. The transcript is about Fate Therapeutics, a biotech company. They discuss clinical trials, product candidates, etc. The concept of "incoming business" vs "outgoing" might not directly apply, but we need to see if they contrast new products/engagements with older ones in terms of quality. Looking at the call: They discuss ProTmune, FATE-NK100, ToleraCyte, and iPSC platform. They talk about progress, but do they contrast the quality of new business vs old? For example, they might say that new clinical trials are better designed, or that they are moving from patient-specific to off-the-shelf, which is better. But is that a contrast of incoming vs outgoing business? They are not really "taking in" orders or contracts; they are developing products. However, they might discuss partnerships or collaborations. For instance, they have a partnership with Memorial Sloan-Kettering, and they licensed IP. But do they say that this new partnership is better than previous ones? Not really. The question is about whether management conveys that the business they are taking in right now is of higher quality than the business they are finishing or replacing. In a biotech context, this could be about moving from one product to another, or from one stage to another. But the transcript doesn't seem to have a clear statement like "our new contracts are better than the old ones" or "we are letting lower-margin business run off." They discuss progress and advancements, but not in terms of economic quality of incoming vs outgoing. They do mention that they are moving from patient-specific therapies to off-the-shelf, which could be seen as a better business model, but they don't explicitly contrast the economics of the new vs old. They also mention that they have a randomized controlled blinded study which is better for registration, but that's about trial design, not about business quality. The question requires both halves: (1) an in-versus-out quality contrast stated by management, and (2) the turnover is real, current, and already in the numbers' future. I don't see management explicitly saying that the business they are taking in now is better than what they are replacing.
Showing the latest 18 of 226 archived research questions.
These archived questions are separate from the newer 500-check scan above.
FATE call history
Open a quarter only when you want its detailed evidence.
D Q3 2023 · Weak call · 2023-11-08Management held guidance steady against contracting margins. The delivery was rich in specifics.
D Q2 2023 · Weak call · 2023-08-08Management held guidance steady against contracting margins. The delivery was rich in specifics.
View the 20 core call-quality checks
F Q1 2023 · Very weak call · 2023-05-03Management held guidance steady against contracting margins. The delivery was frequently evasive.
View the 20 core call-quality checks
F Q4 2022 · Very weak call · 2023-02-28Management gave no formal guidance against contracting margins. The delivery was unusually candid.
View the 20 core call-quality checks
D Q3 2022 · Weak call · 2022-11-03Management raised guidance against contracting margins. The delivery was rich in specifics.
View the 20 core call-quality checks
D Q2 2022 · Weak call · 2022-08-04Management held guidance steady against contracting margins. The delivery was promotional in tone.
View the 20 core call-quality checks
D Q1 2022 · Weak call · 2022-05-04Management held guidance steady against contracting margins. The delivery was rich in specifics, promotional in tone.
View the 20 core call-quality checks
View 25 earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|---|---|---|---|---|---|---|
| Q4 2021 | 2022-02-28 | D | none | unclear | unclear | 6/9 | 4/9 |
| Q3 2021 | 2021-11-05 | D | none | accelerating | contracting | 6/9 | 4/9 |
| Q2 2021 | 2021-08-04 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q1 2021 | 2021-05-05 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q4 2020 | 2021-02-25 | C | none | unclear | contracting | 6/9 | 3/9 |
| Q3 2020 | 2020-11-06 | D | none | unclear | contracting | 7/9 | 3/9 |
| Q2 2020 | 2020-08-05 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q1 2020 | 2020-05-12 | D | none | unclear | contracting | 7/9 | 3/9 |
| Q4 2019 | 2020-03-03 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q3 2019 | 2019-11-05 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q2 2019 | 2019-08-06 | C | none | unclear | contracting | 7/9 | 2/9 |
| Q1 2019 | 2019-05-07 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q4 2018 | 2019-03-05 | D | none | stable | contracting | 6/9 | 3/9 |
| Q3 2018 | 2018-11-02 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q2 2018 | 2018-08-06 | D | none | unclear | contracting | 7/9 | 4/9 |
| Q1 2018 | 2018-05-10 | C+ | none | unclear | contracting | 7/9 | 2/9 |
| Q4 2017 | 2018-03-05 | D | none | unclear | contracting | 6/9 | 3/9 |
| Q3 2017 | 2017-11-02 | D | maintained | unclear | contracting | 6/9 | 4/9 |
| Q2 2017 | 2017-08-15 | D | none | unclear | contracting | 6/9 | 4/9 |
| Q1 2017 | 2017-05-15 | C | none | unclear | contracting | 6/9 | 1/9 |
| Q4 2016 | 2017-03-16 | F | none | unclear | unclear | 6/9 | 5/9 |
| Q3 2016 | 2016-11-07 | C | none | unclear | contracting | 6/9 | 2/9 |
| Q2 2016 | 2016-08-08 | D | none | unclear | contracting | 5/9 | 3/9 |
| Q1 2016 | 2016-05-09 | D | none | unclear | contracting | 6/9 | 5/9 |
| Q4 2015 | 2016-03-03 | C | none | unclear | contracting | 7/9 | 2/9 |